Port systems for vascular access in patients with de novo oncology disease for whom multiple chemotherapy sessions are intended. The most sound solution is the port system application at the earliest chemotherapy stage prior to peripheral phlebitis occurrence.
Due to lack of ambient contact, the port system contamination risk is the lowest.
An operating period to be specified individually according to indications, 3-5 years maximum.
Advantages:
Immediate vascular access when it is necessary to administer medicines or for blood counts
Risk reduction as for occurrence of associated phlebitis
Allows multiple administration of irritant medicines (chemotherapeutic agents), reduces pain.
